Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH - Concepedia

Concepedia

Publication | Open Access

Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH

DOI Full Paper Access

84

Citations

45

References

2022

Year

Vlad Ratziu, Stephen A. Harrison, V. Loustaud‐Ratti, Christophe Bureau, Eric Lawitz, Manal F. Abdelmalek, Naim Alkhouri, Sven Francque, Hugo Girma, Raphaël Darteil,

Journal of Hepatology

Renal ImprovementsFibrosisHepatologyMedicineLiver PhysiologyFibrotic NashPathologyFxr Agonist VonafexorPharmacotherapyLiver DiseaseHepatology FibrosisPharmacologyDrug-induced Liver InjuryNephrology

References

	Year	Citations

Page 1

Page 1